Literature DB >> 22683145

[Polypharmacy in frail elderly patients: is deprescribing the answer?].

Enrique Gavilán-Moral1, Antonio Villafaina-Barroso, Laura Jiménez-de Gracia, María del Carmen Gómez Santana.   

Abstract

Deprescribing is the process of reconstructing multiple medication use by review and analysis and which concludes with dose modification, replacement or elimination of some drugs or adding others. Its development is intended to resolve tensions and contradictions between two sets of questions: 1/is life expectancy shorter than the time the drug takes to obtain a benefit?, and 2/are the goals of prescribing-deprescribing consistent with those of care? The validity of the rationale on deprescribing is based on scientific and ethical reasons. The usefulness and safety of many drugs that frail elderly or terminally ill takes is unknown, and other drugs may cause troublesome or severe side effects. Thus, in some cases their removal could be justified, being substantially safe doing so.
Copyright © 2012 SEGG. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22683145     DOI: 10.1016/j.regg.2012.01.003

Source DB:  PubMed          Journal:  Rev Esp Geriatr Gerontol        ISSN: 0211-139X


  9 in total

1.  Spanish list of potentially inappropriate drugs in the elderly (ES-PIA project).

Authors:  Magali Gonzalez-Colaço Harmand; Ana María Aldea-Perona; Carlos Boada-Fernández Del Campo; Almudena Areosa-Sastre; Consuelo Rodríguez-Jiménez; Marcelino García Sánchez-Colomer; Eduardo Fernández Quintana; Mercedes Plasencia-Nuñez; Paula Masiero-Aparicio; Candelaria Grillo-Grillo; Andrés Orellana-Mobilli; Mar García Sáiz; Carmen Duarte Diéguez; Mercedes Hornillos Calvo; Juan Antonio Avellana Zaragoza; Nicolás Martínez Velilla; Domingo de Guzmán Pérez Hernández; Mario Ruiz González; Encarnación Blanco Reina; Carmen Asensio Ostos; Ana Peiró; Lourdes Cabrera García; Fuensanta Hortigüela Moro; Herlinda Pérez Alayón; Iriana Espárrago García; Javier Santana Quilez; Javier Alonso Ramírez; Carlos Fernández Oropesa; Mª José López Varona; Mª Teresa Acín Gerico; Emilio Sanz Alvarez; María Ángeles Martín de la Sierra; María José Peñalver; Teresa Falomir Gómez; Jesús Ruiz Salazar; Gabriela Elizondo Rivas; Edmundo Rey Rodríguez
Journal:  Eur J Clin Pharmacol       Date:  2019-05-08       Impact factor: 2.953

Review 2.  Deprescribing of non-antiretroviral therapy in HIV-infected patients.

Authors:  José-Ramón Blanco; Ramón Morillo; Vicente Abril; Ismael Escobar; Enrique Bernal; Carlos Folguera; Fátima Brañas; Mercedes Gimeno; Olatz Ibarra; José-Antonio Iribarren; Alicia Lázaro; Ana Mariño; María-Teresa Martín; Esteban Martinez; Luis Ortega; Julian Olalla; Aguas Robustillo; Matilde Sanchez-Conde; Miguel-Angel Rodriguez; Javier de la Torre; Javier Sanchez-Rubio; Montse Tuset
Journal:  Eur J Clin Pharmacol       Date:  2019-12-21       Impact factor: 2.953

3.  Pharmacist comprehensive review of treatment compared with STOPP-START criteria to detect potentially inappropriate prescription in older complex patients.

Authors:  E Delgado-Silveira; M S Albiñana-Pérez; M Muñoz-García; M García-Mina Freire; E M Fernandez-Villalba
Journal:  Eur J Hosp Pharm       Date:  2016-11-23

4.  [Multimorbidity in general practice and the Ariadne principles. A person-centred approach].

Authors:  Alexandra Prados-Torres; Isabel Del Cura-González; Juan Daniel Prados-Torres; Francisca Leiva-Fernández; Juan Antonio López-Rodríguez; Amaia Calderón-Larrañaga; Christiane Muth
Journal:  Aten Primaria       Date:  2017-04-17       Impact factor: 1.137

5.  Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia.

Authors:  M Àngels Pons-Mesquida; Míriam Oms-Arias; Eduard Diogène-Fadini; Albert Figueras
Journal:  BMC Med Inform Decis Mak       Date:  2021-12-15       Impact factor: 2.796

6.  Effect of COVID-19 on quality of life of persons aged >70 years with adult spinal deformity: A cross-sectional case-control study.

Authors:  María Luz Suárez-Huerta; Alejandro Gomez-Rice; Miguel Carvajal Alvarez; Iria Carla Vazquez Vecilla; Enrique Izquierdo-Nuñez; Manuel Fernandez-Gonzalez; Lorenzo Zuñiga-Gómez; Jesus Betegon-Nicolas; Sonia Sanchez-Campos
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

Review 7.  Deprescription: The prescription metabolism.

Authors:  Gurusamy Sivagnanam
Journal:  J Pharmacol Pharmacother       Date:  2016 Jul-Sep

8.  [Deprescribing symptomatic slow acting drugs for osteoarthritis].

Authors:  Eladio Fernández-Liz; Natalia López-Pareja; Assumpta Rifà-Ros; Maite Maudos-Pérez
Journal:  Aten Primaria       Date:  2014-05-16       Impact factor: 1.137

9.  [Deprescribing to increase people health or when deprescribing could be the best pill].

Authors:  Óscar Esteban Jiménez; María Pilar Arroyo Aniés; Caterina Vicens Caldentey; Francisca González Rubio; Miguel Ángel Hernández Rodríguez; Mara Sempere Manuel
Journal:  Aten Primaria       Date:  2018-09-29       Impact factor: 1.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.